Favorsun, a leading domestic enterprise in silk fibroin biomaterials and an industry benchmark, has contributed to the formulation of the industry standard YY/T 1950-2024 "Tissue Engineering Medical Devices – Silk Fibroin".

Leveraging the material’s exceptional physicochemical properties, biocompatibility, biodegradability, and non-immunogenicity, Favorsun focuses on biomedical tissue engineering repair, explores the consumer healthcare market, and primarily operates in the fields of medical devices and medical materials.

Rooted in silk fibroin innovation and driven by the robust R&D capabilities of Fudan University, Favorsun collaborates globally to realize a vision of sustainable and thriving life vitality.